Home
Strides Pharma Science Ltd Board of Directors
Board of Directors at Strides Pharma Science Ltd
Director (Business Developmnt)
Non-Exec. & Independent Dir.
Executive Chairman & M.D.
Managing Director & Group CEO
Non-Exec. & Independent Dir.
Key Highlights
- Arun Kumar joins the board as Executive Chairman & M.D., in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Manjula Ramamurthy continues to serve as the Company Sec. & Compli. Officer in 2024, maintaining the same position as in the previous year.
- Homi Rustam Khusrokhan continues to serve as the Non-Exec. & Independent Dir. in 2024, maintaining the same position as in the previous year.
- Badree Komandur joins the board as Managing Director & Group CEO, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Kausalya Santhanam joins the board as Non-Exec. & Independent Dir., in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.

Strides Pharma Science Ltd
NSE: STAR
Share Price
Last Ten Days Market Price
Date | |
---|---|
17 Apr 2025 | 652.75 |
16 Apr 2025 | 666.3 |
15 Apr 2025 | 619.05 |
11 Apr 2025 | 615.1 |
09 Apr 2025 | 584.05 |
08 Apr 2025 | 593.95 |
07 Apr 2025 | 577.4 |
04 Apr 2025 | 622.65 |
03 Apr 2025 | 699.55 |
02 Apr 2025 | 669.65 |
Company Fundamentals for Strides Pharma Science Ltd
Market Cap
6,015 Cr
EPS
28.1
P/E Ratio (TTM)
23.2
P/B Ratio (TTM)
2.7
Day’s High
666.3
Day’s Low
646.7
DTE
1.0
ROE
8.1
52 Week High
785.85
52 Week Low
301.04
ROCE
11.7
Market Price of Strides Pharma Science Ltd
1M
1Y
3Y
5Y
Strides Pharma Science Ltd News Hub
Strides Alathur successfully concludes USFDA inspection
Strides Alathur, a wholly owned subsidiary of Strides Pharma Science (Strides) has received an Estab
Read more
19 Aug 24
Strides Pharma arm gets EIR from USFDA for Chennai facility
The good manufacturing practices (GMP) inspection was conducted from 1 April to 5 April 2024. The US
Read more
19 Aug 24
Strides Pharma hits 52-week high after dissolution of US unit
Strides Pharma, as a part of Group entites optimization exercises has liquidated its US unit by the
Read more
16 Aug 24
Strides Pharma Science to hold EGM
Strides Pharma Science announced that an Extra Ordinary General Meeting (EGM) of the Company will be
Read more
09 Aug 24